학술논문

Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers
Document Type
Article
Source
In ESMO Open February 2022 7(1)
Subject
Onco-Immunology
Language
ISSN
2059-7029